The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Anticipated Rise In Market Value Of The Immunohistochemistry (IHC) Market During The Forecast Period?
The immunohistochemistry (ihc) market size has experienced substantial growth in recent years. It is forecast to increase from $2.76 billion in 2025 to $3.05 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.3%. This historical expansion can be attributed to factors like the increasing application of ihc in cancer diagnostics, the enlargement of hospital pathology laboratories, greater availability of monoclonal antibodies, the rising acceptance of tissue-based diagnostics, and intensified clinical research activities.
The immunohistochemistry (ihc) market size is projected to undergo substantial expansion over the next few years. It is expected to reach $4.47 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.1%. This anticipated growth during the forecast period can be attributed to increasing demand for precision oncology diagnostics, rising adoption of ai-enabled pathology analysis, expansion of biomarker-driven drug development, growing use of multiplex tissue profiling, and increasing investments in advanced pathology infrastructure. Significant trends for the forecast period include increasing adoption of automated ihc staining systems, rising use of multiplex ihc techniques, growing integration of digital pathology platforms, expansion of companion diagnostic applications, and an enhanced focus on high-specificity antibodies.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9267&type=smp
Which Strong Drivers Are Impacting The Immunohistochemistry (IHC) Market Growth?
The increasing demand for personalized medicines is projected to boost the growth of the immunohistochemistry (IHC) market in the future. Personalized medicine is a medical strategy that involves customizing medical decisions, practices, interventions, and products for individual patients based on their distinct genetic, environmental, and lifestyle attributes. Immunohistochemistry (IHC) holds a vital role in personalized medicine by detecting specific protein markers, which aids in accurate tumor classification and diagnosis. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit research organization, stated that personalized medicines made up more than one-third of new approvals by the US Food and Drug Administration in 2023. In the same year, the FDA approved 16 new personalized treatments for rare-disease patients, an increase from 6 in 2022. As a result, the expanding demand for personalized medicines is driving the growth of the immunohistochemistry (IHC) market.
How Are Segments Identified Within The Immunohistochemistry (IHC) Market Segment Framework?
The immunohistochemistry (ihc) market covered in this report is segmented –
1) By Product: Antibodies, Equipment, Reagents, Kits
2) By Applications: Diagnostics, Drug Testing, Other Applications
3) By End-Users: Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users
Subsegments:
1) By Antibodies: Primary Antibodies, Secondary Antibodies, Conjugated Antibodies
2) By Equipment: IHC Staining Systems, Slide Scanners, Microscopes
3) By Reagents: Detection Reagents, Blocking Reagents, Mounting Media
4) By Kits: Pre-prepared IHC Kits, Multiplex IHC Kits, Specialty Kits
Which Trends Are Contributing To Changes In The Immunohistochemistry (IHC) Market?
Leading companies operating in the immunohistochemistry (IHC) market are prioritizing enhancements in diagnostic accuracy by utilizing innovative technologies and premium reagents, aiming to improve the efficiency of tissue analysis across various clinical and research applications. The Neoflex multiomics mass spectrometry imaging (MSI) system serves as an advanced imaging platform, specifically engineered for precise tissue analysis. This system empowers researchers to transition from initial discovery stages to clinical applications through high-resolution mass spectrometry techniques, particularly for the spatial mapping of biomolecules within tissues. For example, in June 2024, Bruker Corporation, a US-based company involved in the development and manufacturing of scientific instruments, analytical, and diagnostic solutions, launched its matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF/TOF) Neoflex Imaging Profiler, designed for mass spectrometry-based tissue imaging. The Neoflex multiomics mass spectrometry imaging (MSI) system addresses the necessity to advance from discovery imaging to clinical tissue research. Its notable features include Bruker’s 10-kHz smartbeam 3D laser, upgraded imaging detectors, and support for OME-TIFF file output when integrated with SCiLS Scope software.
Who Are The Companies Competing Within The Immunohistochemistry (IHC) Market?
Major companies operating in the immunohistochemistry (ihc) market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., PHC Holdings Corporation, Leica Biosystems, Vector Laboratories, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited, LifeSpan BioSciences Inc., Enzo Life Sciences Inc., Epitomics Inc., GenScript Biotech
Get The Full Immunohistochemistry (IHC) Market Report:
https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report
Which Region Accounts For The Largest Portion Of The Immunohistochemistry (IHC) Market?
North America was the largest region in the immunohistochemistry (IHC) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (ihc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Immunohistochemistry (IHC) Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=9267&type=smp
Browse Through More Reports Similar to the Global Immunohistochemistry (IHC) Market 2026, By The Business Research Company
Immunohematology Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report
Immunoassay Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report
Immunotoxin Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunotoxin-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model